NASDAQ:JYNT - Joint Stock Price, Forecast & News

Joint trades on the NASDAQ under the ticker symbol "JYNT."

Joint Corp (NASDAQ:JYNT) posted its earnings results on Thursday, November, 7th. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.01. The firm earned $12.73 million during the quarter, compared to analyst estimates of $11.60 million. Joint had a net margin of 6.57% and a return on equity of 104.54%. View Joint's Earnings History.

Joint is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Joint.

Joint updated its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $$47.71-48.811 million, compared to the consensus revenue estimate of $$46.32 million.

5 brokers have issued 1-year price objectives for Joint's shares. Their forecasts range from $23.00 to $32.00. On average, they expect Joint's share price to reach $26.60 in the next twelve months. This suggests a possible upside of 54.7% from the stock's current price. View Analyst Price Targets for Joint.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Joint.

News headlines about JYNT stock have trended extremely negative this week, according to InfoTrie. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Joint earned a media sentiment score of -4.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 3.0 out of 10, indicating that recent news coverage is unlikely to have an impact on the stock's share price in the next several days. View News Stories for Joint.

Some companies that are related to Joint include Digital Turbine (APPS), Liberty Tax (TAXA), Quarterhill (QTRH), Acacia Research (ACTG), Research Frontiers (REFR), Finjan (FNJN), XCel Brands (XELB), Health Discovery (HDVY), ARC Group (ARCK), XpresSpa Group (XSPA), Marathon Patent Group (MARA), MGT Capital Investments (MGTI), Spherix (SPEX), Patriot Scientific (PTSC) and American Restaurant Partners LP Class A Partnership Units (ICTPU).

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Advanced Micro Devices (AMD), Starbucks (SBUX), salesforce.com (CRM), Adobe (ADBE), Enphase Energy (ENPH), Etsy (ETSY), Lululemon Athletica (LULU), Walt Disney (DIS), Boxlight (BOXL) and Catalyst Pharmaceuticals (CPRX).

(JYNT) raised $20 million in an initial public offering (IPO) on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company served as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Joint's stock is owned by many different of retail and institutional investors. Top institutional investors include Skylands Capital LLC (3.87%), State Street Corp (1.77%), Granahan Investment Management Inc. MA (1.54%), Cadence Capital Management LLC (1.09%), Millennium Management LLC (0.63%) and Calamos Advisors LLC (0.55%). Company insiders that own Joint stock include Glenn J Krevlin, James H Amos Jr, John P Meloun, Peter D Holt and Ronald V Davella. View Institutional Ownership Trends for Joint.

JYNT stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Skylands Capital LLC, Cetera Advisors LLC and Perkins Capital Management Inc.. Company insiders that have sold Joint company stock in the last year include Glenn J Krevlin and Ronald V Davella. View Insider Buying and Selling for Joint.

JYNT stock was bought by a variety of institutional investors in the last quarter, including Cadence Capital Management LLC, Calamos Advisors LLC, State Street Corp, Russell Investments Group Ltd., Strs Ohio, Squarepoint Ops LLC, Man Group plc and SG Americas Securities LLC. Company insiders that have bought Joint stock in the last two years include James H Amos Jr and Peter D Holt. View Insider Buying and Selling for Joint.

Shares of JYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of JYNT stock can currently be purchased for approximately $17.19.

Joint has a market capitalization of $238.30 million and generates $31.79 million in revenue each year. The company earns $250,000.00 in net income (profit) each year or $0.04 on an earnings per share basis. Joint employs 138 workers across the globe.View Additional Information About Joint.

The official website for Joint is http://www.thejoint.com/.

Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-245-5960 or via email at [email protected]